High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care Settings

Christos Lionis, Marilena Anastasaki, Antonios Bertsias, Agapi Angelaki, Axel C. Carlsson, Hrafnhildur Gudjonsdottir, Per Wändell, Anders Larrabee Sonderlund, Trine Thilsing, Jens Søndergaard, Bohumil Seifert, Norbert Kral, Niek J De Wit, Monika Hollander, Joke Korevaar and François Schellevis
Additional contact information
Christos Lionis: Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
Marilena Anastasaki: Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
Antonios Bertsias: Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
Agapi Angelaki: Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
Axel C. Carlsson: Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 14183 Huddinge, Sweden
Hrafnhildur Gudjonsdottir: Centre for Epidemiology and Community Medicine, Region Stockholm, 11365 Stockholm, Sweden
Per Wändell: Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 14183 Huddinge, Sweden
Anders Larrabee Sonderlund: Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
Trine Thilsing: Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
Jens Søndergaard: Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
Bohumil Seifert: Institute of General Practice, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
Norbert Kral: Institute of General Practice, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
Niek J De Wit: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
Monika Hollander: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
Joke Korevaar: Nivel Netherlands Institute for Health Services Research, 3513 CR Utrecht, The Netherlands
François Schellevis: Nivel Netherlands Institute for Health Services Research, 3513 CR Utrecht, The Netherlands

IJERPH, 2020, vol. 17, issue 23, 1-15

Abstract: (1) Background: Cardiometabolic diseases are the most common cause of death worldwide. As part of a collaborative European study, this paper aims to explore the implementation of primary care selective-prevention services in five European countries. We assessed the implementation process of the selective-prevention services, participants’ cardiometabolic profile and risk and participants’ evaluation of the services, in terms of feasibility and impact in promoting a healthy lifestyle. (2) Methods: Eligible participants were primary care patients, 40–65 years of age, without any diagnosis of cardiometabolic disease. Two hundred patients were invited to participate per country. The extent to which participants adopted and completed the implementation of selective-prevention services was recorded. Patient demographics, lifestyle-related cardiometabolic risk factors and opinions on the implementation’s feasibility were also collected. (3) Results: Acceptance rates varied from 19.5% (n = 39/200) in Sweden to 100% (n = 200/200) in the Czech Republic. Risk assessment completion rates ranged from 65.4% (n = 70/107) in Greece to 100% (n = 39/39) in Sweden. On a ten-point scale, the median (25–75% quartile) of participant-reported implementation feasibility ranged from 7.4 (6.9–7.8) in Greece to 9.2 (8.2–9.9) in Sweden. Willingness to change lifestyle exceeded 80% in all countries. (4) Conclusions: A substantial variation in the implementation of selective-prevention receptiveness and patient risk profile was observed among countries. Our findings suggest that the design and implementation of behavior change cardiometabolic programmes in each country should be informed by the local context and provide some background evidence towards this direction, which can be even more relevant during the current pandemic period.

Keywords: cardiometabolic diseases; cardio-vascular diseases; feasibility study; prevention; primary care; risk reduction (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/17/23/9080/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/23/9080/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2020:i:23:p:9080-:d:457175

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().